TSH-induced hyperthyroidism caused by a pituitary tumor

Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):524-8; quiz following p528. doi: 10.1038/ncpendmet0276.

Abstract

Background: A 45-year-old man presented with frontal headache and visual disturbances to our clinic. For the previous 5 years, he had been receiving treatment for long-lasting mild hyperthyroidism with antithyroid therapy, but therapy had not been carefully followed. During the last 2 years he had also complained of erectile dysfunction and loss of libido. On physical examination, he had a small goiter, normal skin, no Graves' ophthalmopathy, normal BMI, and reduced testis volume and pubic hair.

Investigations: Serum levels of free T3 and T4, serum prolactin, testosterone, serum gonadotropins, insulin-like growth factor 1, adrenocorticotropic hormone, and cortisol were measured. MRI scan, TSH-releasing hormone test, and T3 suppression test were carried out. Levels of pituitary glycoprotein hormone alpha-subunit and sex-hormone-binding protein were also measured.

Diagnosis: Hyperthyroidism caused by a mixed pituitary adenoma that secretes prolactin and TSH.

Management: Trans-sphenoidal resection of the pituitary tumor. After surgery, T3 suppression test failed to completely suppress TSH secretion, which suggested a persistence of residual adenomatous cells. Hyperthyroidism and hypogonadism recurred after 5 years, therefore, treatment with lanreotide was initiated, and resulted in complete resolution of signs and symptoms of the disease.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / complications*
  • Adenoma / diagnosis
  • Adenoma / metabolism
  • Adenoma / surgery
  • Antithyroid Agents / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Hyperthyroidism / diagnosis
  • Hyperthyroidism / drug therapy
  • Hyperthyroidism / etiology*
  • Hyperthyroidism / metabolism
  • Male
  • Middle Aged
  • Octreotide / therapeutic use
  • Peptides, Cyclic / therapeutic use
  • Pituitary Neoplasms / complications*
  • Pituitary Neoplasms / diagnosis
  • Pituitary Neoplasms / metabolism
  • Pituitary Neoplasms / surgery
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use
  • Thyrotropin / metabolism*

Substances

  • Antithyroid Agents
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin
  • Thyrotropin
  • Octreotide